2025.08
Transin Joined BIOMED-X Expo to Showcase Innovation (Aug 7-8)
Transin proudly participated in the BIOMED-X Expo, held on August 7–8, 2025 at the Taoyuan Convention Center. As Taiwan’s premier biomedical startup matchmaking event, BIOMED-X brought together investors, clinical partners, international distributors, and CDMO experts. At the event, Transin highlighted its latest medical device innovations and explored new collaboration opportunities to accelerate commercialization and global market expansion. Our team is excited about the valuable connections made at BIOMED-X and looks forward to turning these opportunities into impactful healthcare solutions worldwide.
VIEW
2025.05
MD&M East 2025 (May 20-22)
TRANSIN proudly participated in the 2025 Medical Design & Manufacturing (MD&M) East exhibition, held from May 20 to 22 at the Jacob K. Javits Convention Center in New York City. As the East Coast's premier medtech event, MD&M East brought together over 4,000 professionals and more than 300 exhibitors across six key sectors: MedTech, automation, packaging, design and manufacturing, plastics, and quality.
VIEW
2024.09
Medica in Germany 2024 (Nov 11-14)
Düsseldorf, Germany – November 11–14, 2024 – Transin Biomedical Co., Ltd. took center stage at MEDICA 2024—the world’s largest medical technology trade fair—held this year at Messe Düsseldorf. As a proud participant in both MEDICA and the concurrent COMPAMED fair, Transin joined over 5,800 exhibitors and welcomed more than 80,000 visitors from more than 165 countries .
MEDICA 2024 reinforced its reputation as a premier hub for medical and med-tech innovation, underscored by vibrant international participation and high-level networking opportunities . Transin’s team welcomed strategic discussions with distributors across Europe, Asia, and the Americas, and secured promising leads for localized production and distribution initiatives.
Buoyed by positive feedback and interest from global audiences, Transin plans to accelerate follow-up actions and deepen partnerships formed at the event. The company remains committed to innovating med-tech solutions that are science-driven, trustworthy, and widely accessible—enhancing patient outcomes both in hospitals and at home worldwide.